严重的肺高血压是肺动脉压缩的次要原因,在霍奇金淋巴瘤治疗后得到解决
Dalia Littman1, Jessica Lovett1, Andrew Adelsheimer2
1Department of Internal Medicine, NYU Grossman School of Medicine, New York, New York, USA.
JACC. Case reports
|July 11, 2025
概括
中质量可以压缩肺动脉 (PA),导致肺高血压. 这种病例显示出PA压缩和肺高血压在霍奇金淋巴瘤化疗后一个月内迅速,完全消失.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
背景情况:
- 肺动脉 (PA) 的外部压缩通过中质量可以导致获得的肺狭窄和肺高血压.
- 这种罕见的疾病通常需要侵入性干预或在几个月内缓慢消失.
研究的目的:
- 报告一个肺动脉压缩和二次肺高血压迅速解决的新案例.
- 突出短间隔回声心脏成像在监测治疗反应中的有用性.
主要方法:
- 一名患有霍奇金淋巴瘤和压缩PA的中质体的27岁妇女接受了化疗治疗.
- 在治疗前和治疗后进行了跨胸腔心声扫描,以评估PA压缩和肺高血压.
主要成果:
- 该患者出现了严重的肺高血压,这是由于PA压缩来自中质量.
- 在化疗后,在一个月内在心声图上观察到PA压缩的快速和完全解消.
- 肺高血压在不需要侵入性干预的情况下消失.
结论:
- 化疗可以导致肺高血压的快速和完整的解决,这是来自中瘤的外部PA压缩的次要原因.
- 这一案例显示了比以前报告的案件更快的解决方案,强调了迅速治疗和监测的重要性.
更多相关视频
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
293
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
293
Pneumothorax-II
380
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
380
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
321
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
321
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
262
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
262
Cardiomyopathy V: Interprofessional Care
37
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
37
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
46
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
46


